ABIOMED, Inc.  

(Public, NASDAQ:ABMD)   Watch this stock  
Find more results for abmd
100.37
-3.88 (-3.72%)
Jun 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 98.01 - 103.98
52 week 60.88 - 110.68
Open 99.00
Vol / Avg. 4.66M/581,744.00
Mkt cap 4.13B
P/E 118.08
Div/yield     -
EPS 0.85
Shares 42.74M
Beta 1.15
Inst. own 98%
Aug 11, 2016
Abiomed Inc Annual Shareholders Meeting (Estimated) - 8:00AM EDT - Add to calendar
Aug 2, 2016
Q1 2017 Abiomed Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 14, 2016
Abiomed Inc at William Blair Growth Stock Conference
Jun 9, 2016
Abiomed Inc at Jefferies Healthcare Conference
May 3, 2016
Q4 2016 Abiomed Inc Earnings Release
May 3, 2016
Q4 2016 Abiomed Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2016
Net profit margin 11.71% 11.58%
Operating margin 21.09% 19.76%
EBITD margin - 20.76%
Return on average assets 10.82% 10.01%
Return on average equity 12.35% 11.55%
Employees 747 -
CDP Score - -

Address

22 CHERRY HILL DR
DANVERS, MA 01923-2575
United States - Map
+1-978-7775410 (Phone)
+1-978-7778411 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company's products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.

Officers and directors

Michael R. Minogue Chairman of the Board, President, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tomsicek Chief Financial Officer, Vice President, Treasurer
Age: 49
Bio & Compensation  - Reuters
David M. Weber Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
William J. Bolt Senior Vice President - Global Product Operations
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Andrew J. Greenfield Vice President, General Manager - Global Marketing
Age: 42
Bio & Compensation  - Reuters
Michael G. Howley Vice President, General Manager - Global Sales and Marketing
Age: 51
Bio & Compensation  - Reuters
Ingrid Goldberg Director - Investor Relations
Bio & Compensation  - Reuters
Dorothy E. Puhy Lead Independent Director
Age: 64
Bio & Compensation  - Reuters
Jeannine M. Rivet Director
Age: 62
Bio & Compensation  - Reuters
Christopher D. Van Gorder Director
Bio & Compensation  - Reuters